Non-Billable / Non-Specific Code
ICD-10-CM D31 is the diagnosis code for Benign neoplasm of eye and adnexa. This code falls under the section "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as D31. They are mutually exclusive:
Understanding where D31 sits in the ICD-10-CM classification helps ensure proper coding:
No, D31 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
D31 is the ICD-10-CM diagnosis code for "Benign neoplasm of eye and adnexa". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
D31 is located in Section D10-D36 — "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
D31 has 8 sub-code(s) that provide more specific detail: D31.0, D31.1, D31.2, D31.3, D31.4 and more.
Use D31 when the patients documented diagnosis matches "Benign neoplasm of eye and adnexa" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Benign neoplasm of eye and adnexa is D31.
No, D31 is non-billable. Use a more specific sub-code for primary diagnosis billing.
D31 is in Chapter 2 of the ICD-10-CM Tabular List.
Type 1 Excludes for D31 include: benign neoplasm of connective tissue of eyelid (D21.0); benign neoplasm of optic nerve (D33.3); benign neoplasm of skin of eyelid (D22.1-, D23.1-).
Yes, D31 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.